Detalles de la búsqueda
1.
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables.
Clin Proteomics
; 20(1): 52, 2023 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37990292
2.
Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms.
Urol Int
; 107(10-12): 924-934, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37939691
3.
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer.
Curr Opin Urol
; 32(6): 607-613, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36101521
4.
PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer.
Urol Int
; 106(9): 920-927, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933313
5.
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
Urol Int
; 106(1): 75-82, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167120
6.
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.
J Urol
; 205(2): 356-369, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32935652
7.
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies.
World J Urol
; 39(6): 1861-1867, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32683462
8.
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy.
Future Oncol
; 17(30): 3987-3994, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278815
9.
Mechanical and Ablative Minimally Invasive Techniques for Male LUTS due to Benign Prostatic Obstruction: A Systematic Review according to BPH-6 Evaluation.
Urol Int
; 105(9-10): 858-868, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849045
10.
Beyond PSA: The Role of Prostate Health Index (phi).
Int J Mol Sci
; 21(4)2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32053990
11.
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials.
World J Urol
; 37(6): 1049-1059, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30519742
12.
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
World J Urol
; 37(3): 507-514, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992381
13.
High-throughput detection of low abundance sialylated glycoproteins in human serum by TiO2 enrichment and targeted LC-MS/MS analysis: application to a prostate cancer sample set.
Anal Bioanal Chem
; 411(3): 755-763, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30483857
14.
High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Urol Int
; 101(1): 7-15, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29975950
15.
Safe introduction of laparoscopic and retroperitoneoscopic nephrectomy in clinical practice: impact of a modular training program.
World J Urol
; 35(5): 761-769, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530745
16.
The emerging role of obesity, diet and lipid metabolism in prostate cancer.
Future Oncol
; 13(3): 285-293, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27624840
17.
Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
Urol Int
; 98(3): 290-297, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28142141
18.
Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS).
Int J Mol Sci
; 18(6)2017 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28555004
19.
Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study.
BMC Cancer
; 16: 59, 2016 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26846521
20.
In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance.
BJU Int
; 118(4): 527-34, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26350955